Methylphenidate hydrochloride
Brand names,
Methylphenidate hydrochloride
Analogs
Methylphenidate hydrochloride
Brand Names Mixture
Methylphenidate hydrochloride
Chemical_Formula
C14H19NO2
Methylphenidate hydrochloride
RX_link
http://www.rxlist.com/cgi/generic/methphen.htm
Methylphenidate hydrochloride
fda sheet
Methylphenidate hydrochloride
msds (material safety sheet)
Methylphenidate hydrochloride
Synthesis Reference
M. Hartmann, L. Panizzon, U.S. Pat. 2,507,631 (1950)
Methylphenidate hydrochloride
Molecular Weight
233.306 g/mol
Methylphenidate hydrochloride
Melting Point
224-226oC
Methylphenidate hydrochloride
H2O Solubility
1255mg/L
Methylphenidate hydrochloride
State
Solid
Methylphenidate hydrochloride
LogP
3.192
Methylphenidate hydrochloride
Dosage Forms
Tablets; Tablets (sustained release)
Methylphenidate hydrochloride
Indication
For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.
Methylphenidate hydrochloride
Pharmacology
Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine.
Methylphenidate hydrochloride
Absorption
Readily absorbed in a biphasic manner. It reaches peak absorption at approximately two hours for the first phase and five hours for the second phase. Bioavailability is low (approximately 30%)
Methylphenidate hydrochloride
side effects and Toxicity
Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)
Methylphenidate hydrochloride
Patient Information
Methylphenidate hydrochloride
Organisms Affected
Humans and other mammals